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Abstract
Background: Syndrome of the trephined is a well-recognised phenomenon that occurs in patients following a
craniectomy. It is associated with several symptoms, including headaches, motor impairments, cognitive disorders
and reduced consciousness. Treatment for the syndrome usually involves replacing the skull defect.
Case Study: A 71-year-old male underwent a left-sided craniectomy after being diagnosed with biopsy-confirmed
invasive squamous cell carcinoma with associated skull erosion. Subsequently, he developed a severe case of
syndrome of the trephined (SoT,) resulting in having to lie flat to prevent the motor component of the Glasgow
Coma Score (GCS) falling from M5/6 (E3/4 Vt M5/6) to M1 (E3/4 Vt M1) on sitting to 30 degrees. Unfortunately, due
to ongoing chest sepsis and physical frailty, he was unable to undergo a cranioplasty. Therefore, to aid in clinical
stabilisation, the treating physicians and clinical engineering teams designed and manufactured a prosthesis on-site,
allowing rapid patient treatment. The prosthesis led to the patient being able to sit up to 30 degrees without the
motor component of the GCS falling from M6 to M1 (E4 VT M6).
Conclusion: Clinical improvements were demonstrated with definitive neurological improvement after applying
the external cranial plate in clinical outcome measures and radiographically. Furthermore, we have shown that
rapid prototyping technology provides a flexible solution to synthesise bespoke medical prostheses with the
correct expertise and regulatory framework.
Introduction
Decompressive craniectomy is a well-recognised neuro-
surgical strategy for reducing intracranial pressure, most
commonly in the setting of traumatic brain injury and
stroke [1], but also for invasive malignancy and infec-
tion. Following craniectomy, there is the potential to re-
construct the bony defect with a range of materials to
protect the underlying brain, improve cosmesis and miti-
gate against the Syndrome of the Trephined (SoT). This
is termed cranioplasty, typically an elective procedure
following the resolution of the original pathology.
Various materials have been utilised for reconstruction,
including autologous bone, hydroxyapatite, polyether-
etherketone (PEEK), polymethylmethacrylate (PMMA),
and titanium. A few case reports [2, 3] report on apply-
ing an external prosthesis, using plaster as the material
of choice for the treatment of SoT in patients who could
not undergo a cranioplasty, as it is easy to manipulate
into shape the bedside and quick to set. In our institu-
tion, Cambridge University Hospitals NHS Foundation
Trust, we have a process for creating implantable
custom-made 3D printed titanium cranial plates. These
are prescribed by the clinician, designed in-house based
on individual patient CT scans, then laser sintered in
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titanium alloy by a third-party manufacturer. Both the
Trust and the manufacturer deliver this within ISO
13,485 quality management systems, and the plates are
classed as custom made medical devices compliant with
the Medical Devices Directive (93/42/EEC). We utilised
this experience in plate design by applying the same
principles in manufacturing the external prosthesis but
using Formlabs Dental SG resin rather than titanium.
Potential advantages of 3D printing in this context are
being accurate, detailed, plate fitting but accepting a
slightly longer time frame from design to the application
than previously described methods using plaster.
SoT, or ‘sunken flap syndrome’, is a poorly understood
complication of a craniectomy, with an incidence of
around 13 % [4] but is very likely to be underestimated,
given our limited understanding of the condition and
under-reporting. It develops slowly over days or weeks
following the craniectomy. However, it can result in
marked neurological dysfunction, which usually im-
proves following cranial reconstruction—first described
by Grant and Norcross in 1939 [5] as a syndrome com-
prising of severe headaches, dizziness with pain at the
craniectomy site and altered cognitive state of mind.
These clinical manifestations of the syndrome are vari-
able, and in the most severe cases result in marked de-
terioration of neurological state, leading to coma,
prolonged admission to intensive care, with increased
risk of secondary complications such as aspiration pneu-
monia and in the longer-term, potential increases in dis-
ability and associated dependency. However, there are
three overarching features [6] that help identify the
syndrome:
 Neurological deficits occurring days, weeks, or
months after the craniectomy.
 The occurrence of neurological deficits separate to
those associated with the initial pathology.
 Clinical resolution after cranioplasty.
Recognition of this syndrome can be clinically challen-
ging, especially in those patients with prolonged
disorders of consciousness (PDOC), where it should be
considered if a sunken flap is present. In those with
likely SoT, expedited cranioplasty is considered to re-
verse the neurological deficit and aid
neurorehabilitation.
This report describes the case of a 71-year-old patient
who was suffering from severe sunken flap syndrome
following a craniectomy and who was not suitable for an
immediate cranioplasty due to chest sepsis and under-
lying physical frailty as a result of his malignancy and
co-morbidities, with a very high risk of mortality associ-
ated with further anaesthesia and surgical intervention.
However, he was managed by successfully
manufacturing a novel external cranial plate device to
improve his symptoms. To our knowledge, this is the
first description of an external prosthesis manufactured
using rapid prototyping technology to be used for an ex-
ternal cranioplasty, but it is a widely practised manufac-
turing process for internal cranioplasties.
Case Study
Initial presentation and plate indication
A 71-year-old male presented to a dermatology clinic in
July 2019 with a left frontal scalp mass and was diag-
nosed with biopsy-confirmed, non-metastatic, invasive
squamous cell carcinoma with associated erosion of the
skull. In August 2019, after a comprehensive multi-
disciplinary team discussion, the patient underwent an
en bloc resection of the lesion, including large left-sided
craniectomy and resection of the underlying involved
dura. The defect was reconstructed with a subsequent
right free flap latissimus dorsi muscle/serratus anterior
fascial flap transfer. Post-operatively, the patient was
managed in the neuro-intensive care unit (NCCU) be-
fore being transferred to the neurosurgical ward. Post-
operatively the patient remained mildly confused, with a
GCS of 14/15 but developed pneumonia and was re-
admitted to the NCCU for respiratory support.
Over the following week, a sunken brain flap devel-
oped concordant with the drop in GCS. Laying the bed
flat to mitigate the sunken flap resulted in an improve-
ment in GCS while raising the head of the bed to 30 de-
grees resulted in a GCS motor score reduction of M6 to
M1 at worst. The patient was repeatedly challenged with
the head of the bed raises over two weeks to assess for
possible resolution of SoT. Unfortunately, given the on-
going risk of infection associated with chest sepsis and
overall physical frailty, the patient could not undergo a
cranioplasty reconstruction. In addition, laying the pa-
tient flat was considered an additional barrier to respira-
tory management. Given the limited therapeutic options
in this circumstance, following a discussion with Clinical
Engineering, the hospital Medical Devices Advisory
Group were approached to conduct an n=1 trial of ex-
ternal plate manufacture to mitigate the symptoms of
the SoT as a bridge to definitive cranioplasty insertion.
The clinical objective was to stabilise the patient’s condi-
tion, enabling the patient to sit up without neurological
compromise and potentially expedite the removal of the
tracheostomy and transfer out of the NCCU.
Medical device development and application
Clinical Engineering Innovation (CEI) is a team of NHS-
funded engineers based within the hospital who design
and manufacture innovative medical technologies to
solve unmet clinical needs for patient benefit. The aim
was to design and manufacture a device to replicate the
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effects of a cranioplasty, thus reducing the neurological
sequelae of SoT.
Following a multi-disciplinary discussion between CEI
and the clinical team, a plan was made to design and
manufacture a custom 3D printed external cranial plate,
building on the in-house expertise within the relevant
departments. A detailed prescription was obtained from
the consultant, who also approved the 3D model of the
plate before printing. Informed consent was obtained
from the patient’s next of kin, and it was explained that
this was a novel device of unknown benefit. The scien-
tific justification for this solution was based on the
known success of traditional implantable cranial
plates[6], with a minimal number of previous case re-
ports demonstrating similar applications [2]. The CEI
team conducted a detailed risk assessment of the pro-
posed external cranial plate with input from clinical col-
leagues. The likelihood and consequence of each hazard
were scored in a risk evaluation table, and risk mitiga-
tions were identified to reduce risks to an acceptable
level. The hazards considered were biological, mechan-
ical and human factors. A biocompatible material was
selected, which was formulated for dental applications.
Silicone adhesive dressings were used to separate the
plate from the patient’s skin to mitigate biocompatibility
risks and protect the wound site. The plate thickness
was specified to reduce the risk of plate shattering. The
patient was closely monitored, and the protocol stated
that the plate should be removed after a maximum of
72 h or earlier if clinically indicated. Manufacture &
quality checking processes were also implemented to
mitigate risks by inspecting sharp edges and stress
propagation points. Based on this risk assessment, the
multi-disciplinary team concluded that residual risks of
a specifically designed external cranial plate were very
low, and the intervention offered potential benefits to
the patient.
ADEPT software is used routinely within the Trust to
design custom implantable cranial plates from CT scans.
This was used to design the external cranial plate follow-
ing an adapted version of the Trust’s standard process
for implantable cranial plates, as described in Fig. 1. A
mirrored model of the intact side of the skull formed the
basis of the plate. In addition, the design was modified
to allow the free-graft pedicle to pass beneath the plate
without compression, and the 3D model was enlarged to
allow space for silicon adhesive dressings to be applied
circumferentially on the patient’s skin to separate the
plate from the patient’s skin and any wounds at the sur-
gical site. The prescribing clinician approved the 3D
model of the final plate design before being sent to
print.
The plate was printed in biocompatible dental SG
resin on a Formlabs Form 2 3D printer, cured and
finished by the CEI team, then sterilised by the in-house
sterile services department. Formlabs Dental SG resin
was chosen because the material data sheet specifies that
the material is biocompatible (adheres to the EN ISO
10993-1:2009/AC:2010 standard), and it is suitable for
Fig. 1 Workflow from CT image file to printable STL file.
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steam sterilisation in an autoclave. Formlabs “Instruc-
tions for Use for Dental SG” and “Application Guide for
3D Printing Surgical Guides with the Form 2” were used
to guide all stages of the manufacturing and sterilisation
process. PreForm software was used to align and orien-
tate the plate model to minimise warping, prevent the
occurrence of minima and cupping, generate the support
structure attached to the outside surface of the plate,
and reduce the thickness of the support touchpoints to
minimise surface blemishing. The plate was printed
using a resin tank and a platform dedicated to prints in
Dental SG resin. After printing, the plate was removed
from the printer, rinsed twice in fresh 90 % isopropyl al-
cohol for 10 min, then air-dried before curing for 30-
40 min in a UV curing oven. The support structure was
removed using flush cutters, and then the plate was
inspected for stress propagation points and sharp edges.
The outer surface was finished with fine sandpaper to
remove any support remnants, then the plate was
inspected and accepted by a member of the CEI team
and sent to the in-house sterilisation department. The
plate was steam-sterilised in an autoclave at 134 °C per
local protocols, then packaged and labelled ready for
use. As described in the Dental SG resin instructions for
use, material colour changes indicated that each step
was completed to create a sterile, biocompatible finished
product (Fig. 2).
The entire design and manufacture process was over-
seen by a multi-disciplinary team consisting of clinicians
and engineers. CEI was responsible for all necessary
technical documentation for a custom-made medical de-
vice for in-house manufacture and used the Medical De-
vice Regulation 2017/475, working within a quality
system accredited to ISO 9001 and ISO 13,485. This
documentation included the prescription from the clin-
ician, patient consent form, risk assessment, technical
drawings of the custom device, Formlabs Dental SG ma-
terial data sheet, custom external cranial plate instruc-
tions for use, sterilisation documentation, device labels,
checklist demonstrating conformance of the device to
the general safety and performance requirements set out
in Annex I of the Medical Device Regulation 2017/475,
and a statement of conformity (as described in Annex
XIII of the Medical Device Regulation 2017/475),). The
collaboration between the clinicians and the in-house
CEI team, combined with the Trust’s existing processes
for implantable titanium cranial plates, enabled the
whole process from inception to application of the de-
vice to occur in less than one week, which would not
have been the case if the clinicians had worked with an
external contractor rather than the internal CEI team.
Indications for plate removal, associated with possible
harm, were agreed with the Medical Devices Advisory
Group, including lack of improvement after 72 h or
further deterioration of the patient’s GCS. Therefore, a
plan was made to incline the patient’s bed over 24 h
gradually, and success would be measured by the record-
ing of the GCS and a CT scan of the brain. In addition,
a plan was made to remove the device after 72 h to re-
place wound dressings and check the viability of the
skin. The observation was carried out in a high depend-
ency environment with written advice to all relevant
medical and nursing professionals.
Adaptic Touch non-adhering silicone dressings were
applied along the edges of the plate to act as a layer of
protection between the plate and skin. Cosmopor E ster-
ile absorbent adhesive dressings were then applied across
the edges of the plate and the patient’s skin to secure
the plate in place (Fig. 3).
Clinical Response
Before the external plate application, the patient could
not sit up to 30 degrees without a drop in the motor
score on the GCS from M6 to M1. However, within
36 h of the device’s application, they could sit up to 45
degrees facilitating chest physio with no drop in the
motor score. Initially, there were some difficulties with
periods of hypotension, but these resolved and were
thought to be related to the physiological effect of lying
flat for a prolonged period before applying the external
plate. The plate was removed for clinical reasons after
three days, not related to the plate application as per the
risk assessment plan.
CT head imaging shows the intracranial changes, with
the sunken flap before the device application (Fig. 4.)
and brain tissue re-expansion (Fig. 5.) 2 days post device
application.
Over the following week, the patient became increas-
ingly drowsy again, dropping the motor score of the
GCS from M6 to M5 while sitting at 45 degrees. Clinic-
ally, it was evident that the patient was again developing
the symptoms of SoT but not to the same severity as the
first occurrence. The plate was re-applied in the same
fashion, and the opportunity was taken to carry out a
more detailed neurological assessment utilising the Wes-
sex Head Injury Matrix (WHIM).
The WHIM is an observational scale designed to
monitor changes in an individual’s level of responsive-
ness and interactions as they regain consciousness. It is
used primarily in patients who have suffered a traumatic
brain injury (TBI) [7]. Although this patient had not suf-
fered a TBI, it was decided that the WHIM would be an
ideal tool to observe small but very relevant changes in
neurology before and after the application of the device.
Patients are scored against the hierarchal scale, and after
ten non-observations in a row, the score of the last com-
pleted observation is used. Before re-application of the
plate, the patient scored 22 on the WHIM. This was
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subsequently repeated 48 h after attachment of the plate,
and the patient scored 38. As in the first application, the
plate was removed after 72 h with the patient being clin-
ically weak but neurologically stable sitting at 45
degrees.
The patient remained clinically stable over the follow-
ing ten days, but increasingly frail secondary to his
underlying pathology and subsequently developed a fur-
ther chest infection. Despite active treatment, further
clinical deterioration occurred, and it was decided to
withdraw active care, and a palliative, end of life care ap-
proach was taken. The patient passed away peacefully a
few days later.
Discussion
This is the first report of an in house designed and man-
ufactured 3D printed prosthesis used to help mitigate
the symptoms of the Syndrome of the Trephined. In
addition, it demonstrates how rapid prototyping technol-
ogy can be flexibly applied to solve novel clinical prob-
lems within appropriate governance and regulatory
framework.
Several proposed theories regarding the underlying
pathophysiology of the syndrome of trephined are
known, with likely multiple mechanisms involved.
Firstly, altered external barometric pressures on the
scalp result in increased pressure across the cerebral
vasculature, leading to decreased cerebral blood flow
and impaired CSF flow, resulting in neurological com-
promise [5]. This has been demonstrated using
xenon-enhanced perfusion CT, in which, following
craniectomy, cerebral blood flow (CBF) both on the
ipsilateral and contralateral sides [8]. CBF, cerebral
perfusion, and CSF circulation disturbances are well
Fig. 2 CT head scan with 3D reconstruction before device application
Fig. 3 CT head scan with 3D reconstruction two days after device application. As the brain surface expands towards the inner surface of the
cranioplasty, the ventricles become enlarged. This is an ex vacuo phenomenon and does not represent hydrocephalus
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described in the chronic phase of acquired brain in-
jury following a craniectomy. Worsening of these
pathophysiological consequences due to the sunken
flap is likely why a subset of patients develop the syn-
drome of trephined, and it is the cranioplasty that
stabilises the atmospheric pressure gradient, re-
establishing the fixed volume of the cranial vault
allowing the brain parenchyma to re-expand with
studies demonstrating improved CSF hydrodynamics
[9–11] and improvements in CBF following a
cranioplasty.
There was an unambiguous clinical improvement in
GCS motor score following application of the cranial
plate, which abated on the removal of the plate and
improved once more on re-application. Although this is
an n=1 study, and no definitive conclusions can be
drawn, the reversible clinical response suggests that it
was the application of the plate that affected the clinical
improvement analogous to the insertion of conventional
'internal’ cranioplasty plates. We hypothesise that a com-
bination of the plate and the dressings limited move-
ment of the skin and subsequent sinking of the flap,
reducing association distortion and recapitulating the
normal CSF hydrodynamic pathways. Alternatively,
sealing the defect from the effects of atmospheric pres-
sure may have prevented cerebral blood flow and CSF
flow impairment, minimising midline shift and brain
slump and axonal stretch. Given that the definitive
mechanism of SoT is not known, we recognise that these
hypotheses are necessarily speculative.
Limitations include how best to secure the device to
the craniectomy site; in this case, Adept dressings were
used but in warm environments, and if the hair was
present, this could prove difficult. Also, although the
plate was manufactured within one week, this is still a
significant period for a patient with neurological com-
promise, and other streamlined design and manufacturer
processes would need to be considered in the future.
Further definitive research is required to better under-
stand the potential benefits of the external cranioplasty
and its pathophysiological consequences concerning the
syndrome of trephined.
Conclusions
This study has two important implications. Firstly, while
3D printing has been proposed as a new method for the
Fig. 4 External cranioplasty before application
Fig. 5 External plate after application
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bespoke design of prostheses in various settings [8, 12],
we believe unique and challenging cases such as this
within the clinical arena can provide the most significant
potential benefit. This novel, safe and inexpensive med-
ical device was designed and made promptly to benefit
the patient’s neurological state directly. Secondly, we
have provided the first description of 3D printed exter-
nal cranioplasty to aid in the clinical stabilisation of a
patient suffering from the syndrome of trephined. This
provides a wholly novel therapeutic strategy in neuror-
ehabilitation following a craniectomy.
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